touchMDT for touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss how patients with endometrial cancer should be tested to determine suitability for PD-1/PD-L1 inhibitor therapy.
The multidisciplinary team
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from GlaxoSmithKline. This activity is provided by touchIME.
For further information visit our website: https://touchoncology.com/education/mdt-for-io-in-ec/
MDT perspectives on the current and emerging second-line treatment options for SCLC
MDT perspectives on managing side effects associated with second-line treatment for SCLC
MDT perspectives on tailoring second-line treatment selection to each patient with relapsed SCLC
MDT perspectives on managing side effects associated with second-line treatment for SCLC
MDT perspectives on tailoring second-line treatment selection to each patient with relapsed SCLC
MDT perspectives on the current and emerging second-line treatment options for SCLC
A patient’s perspective: Best practice for shared decision making in the prevention and treatment of migraine
Optimizing outcomes for patients with Alzheimer’s disease: A focus on transdermal therapy
What are the implications of the latest data for HER2-targeted therapies in HER2-tested patients with colorectal cancer?
Improving outcomes in severe paediatric asthma: Insights from a specialist and a PCP
Improving outcomes in severe paediatric asthma: Insights from a specialist and a PCP
Tackling unmet needs in chronic myeloid leukemia What’s next in the treatment algorithm
MDT perspectives on preventing or delaying TSC-associated seizures
MDT and patient caregiver perspectives on emerging agents for TSC-associated seizures
MDT and patient caregiver perspectives on the treatment options for TSC-associated seizures
Prurigo nodularis: Improving awareness, diagnosis, management and quality of life
Achieving best practice management of primary biliary cholangitis now and in the future
Achieving best practice management of primary biliary cholangitis now and in the future
Scanning the horizon of pharmacological treatments for women experiencing vasomotor symptoms during menopause What’s new in 2022
PARP inhibitors as first-line maintenance therapy in ovarian cancer: How can data from ESGO 2022 guide clinical practice?
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain